VYOME HOLDINGS, INC. Total Liabilities and Equity
VYOME HOLDINGS, INC. (HIND) had Total Liabilities and Equity of $9.18 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-12
- 2026-06-30: Liabilities and Equity $9.18M.
- 2026-03-31: Liabilities and Equity $10.19M.
- 2025-12-31: Liabilities and Equity $6.50M.
- 2025-09-30: Liabilities and Equity $7.05M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $9.18M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $10.19M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $6.50M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $7.05M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.63M 8-K · filed 2025-09-02 | $9.03M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $6.48M 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $1.38M 10-K · filed 2026-03-18 | $4.79M 10-K · filed 2025-04-04 |
| 2024-09-30 | $5.62M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $6.39M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $8.23M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $10.66M 10-K · filed 2025-04-04 | |
| 2023-09-30 | $7.83M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $11.85M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $16.35M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $11.14M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $26.48M 10-K · filed 2023-04-17 | $28.46M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $40.36M 10-K · filed 2023-04-17 | $41.92M 10-Q · filed 2022-08-19 |
| 2022-03-31 | $45.62M 10-K · filed 2023-04-17 | $47.27M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $52.53M 10-K · filed 2023-04-17 | $54.26M 10-K · filed 2022-04-08 |
| 2021-09-30 | $90.79M 10-K · filed 2023-04-17 | $90.70M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $120.01M 10-K · filed 2023-04-17 | $120.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $17.34M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $37.06M 10-K · filed 2022-04-08 | $10.62M 10-K · filed 2021-03-12 |
| 2020-09-30 | $11.96M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $13.87M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $19.23M 10-Q · filed 2020-06-19 | |
| 2019-12-31 | $20.39M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $24.66M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $19.20M 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $32.37M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $30.39M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $36.88M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $32.47M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $40.51M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $53.10M 10-K · filed 2019-02-22 | |
| 2017-09-30 | $59.08M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $64.98M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $70.59M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $78.78M 10-K · filed 2018-03-05 | |
| 2016-09-30 | $18.50M 10-Q · filed 2016-11-10 | |
| 2015-12-31 | $14.22M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |